• Cinoxacin Workflows: Precision Tools for Quinolone Antibioti

  2026-07-29

  Cinoxacin, a quinolone antibiotic, enables high-fidelity modeling of Gram-negative bacterial infections in translational research. This article delivers actionable protocols, comparative insights, and troubleshooting expertise for urinary tract infection and antibiotic resistance studies—empowering researchers to achieve reproducible results with APExBIO's trusted Cinoxacin.

• MOG (35-55) Peptide: Advancing Multiple Sclerosis Research

  2026-07-28

  MOG (35-55) Peptide stands as the benchmark for inducing experimental autoimmune encephalomyelitis, enabling robust modeling of neuroinflammation in multiple sclerosis research. Discover enhanced workflows, troubleshooting strategies, and the impact of PARP7 pathway insights for translational breakthroughs.

• Bradford Protein Assay Kit: Technical Workflow for Protein Q

  2026-07-28

  The Bradford Protein Assay Kit enables rapid, sensitive, and reproducible measurement of protein concentrations in research samples. It is best employed for routine quantification in molecular biology, enzyme assays, and protein purification where sample composition is compatible. Researchers should avoid using this kit for absolute quantification of atypical proteins or samples containing interfering detergents.

• 5X Protein Loading Buffer (Reducing): SDS-PAGE Technical Gui

  2026-07-27

  5X Protein Loading Buffer (Reducing) enables consistent protein denaturation and disulfide bond reduction for accurate molecular weight separation in SDS-PAGE analysis. This buffer should be used only when fully denatured and reduced protein samples are required, and is not suitable for workflows that require preservation of native or non-reducing conditions.

• Intravesical p21 mRNA-LNP Therapy for Bladder Cancer: Innova

  2026-07-27

  This article examines a recent study demonstrating that intravesical delivery of p21 mRNA-loaded lipid nanoparticles (LNPs) offers a potent, localized tumor suppressor replacement strategy for bladder cancer. The research details robust in vitro and in vivo antitumor effects, innovative use of mRNA-LNP technology, and provides insights for translational molecular research.

• BI 2536: Optimizing PLK1 Inhibition for Advanced Cancer Rese

  2026-07-26

  BI 2536 stands out as a gold-standard PLK1 inhibitor for dissecting mitotic checkpoint control and apoptosis in cancer research. This guide translates leading-edge mechanistic insights and practical workflows—anchored by recent reference studies—into actionable, reproducible protocols for in vitro and in vivo applications.

• Fluorouracil in Solid Tumor Research: Protocols and Innovati

  2026-07-25

  Fluorouracil (Adrucil) empowers cancer researchers with precision protocols, robust inhibition of DNA replication, and reproducible outcomes in colon, breast, and other solid tumor models. This guide details advanced workflows, key troubleshooting strategies, and translates the latest mechanistic insights into actionable experimental enhancements.

• ERAD-Hijacking Chimeras Enable Targeted TM Protein Degradati

  2026-07-24

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule technology that selectively harnesses the ER-associated degradation pathway for targeted removal of transmembrane proteins. This approach surpasses previous limitations in membrane protein degradation, offering researchers novel mechanistic and therapeutic possibilities.

• MLKL Polymerization Triggers Lysosomal Permeabilization in N

  2026-07-24

  This study reveals that MLKL polymerization induces lysosomal membrane permeabilization (LMP), releasing cathepsin B and driving necroptotic cell death. The findings clarify the critical sequence linking MLKL activation, LMP, and cathepsin-mediated cell death, informing targeted approaches in cell death and inflammation research.

• Direct Enzymatic Synthesis of Fatty Amines from Trilaurin

  2026-07-23

  This study demonstrates a high-yield, one-pot enzymatic cascade for synthesizing primary fatty amines directly from renewable triglycerides such as Trilaurin. By integrating lipase, carboxylic acid reductase, and transaminase, the process avoids harsh conditions and toxic catalysts, offering a sustainable alternative for fatty amine production.

• Tropisetron Hydrochloride: Precision Tools for Serotonin 5-H

  2026-07-23

  Explore the advanced utility of Tropisetron Hydrochloride as a 5-HT3 receptor antagonist in serotonin signaling research. This article delivers actionable insights for optimizing neuroscience receptor modulation and highlights unique protocol considerations that transcend standard workflow guides.

• Leucomycin (Kitasamycin): Precision Design for Bacterial Gro

  2026-07-22

  Explore how Leucomycin (kitasamycin) enables highly specific bacterial growth inhibition assays by integrating mechanistic insights and evidence-based protocol design. This article reveals advanced strategies for translational inhibition studies and macrolide resistance analysis.

• PP 3: Advancing Src Kinase Pathway Research with Rigorous Co

  2026-07-22

  Discover how the research use only chemical 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) enhances specificity and reliability in Src kinase signaling pathway research. This article uniquely examines protocol decisions, mechanistic implications, and landmark evidence for rigorous kinase pathway assay design.

• Quinolone–Coumarin Hybrids Show Promise Against Toxoplasma g

  2026-07-21

  This study evaluates novel quinolone–coumarin hybrids, derived from fluoroquinolone scaffolds and novobiocin, for in vitro activity against Toxoplasma gondii. Select hybrids demonstrated potent antiparasitic effects with higher selectivity than standard therapies, offering a new direction for anti-toxoplasmosis drug development.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe Gui

  2026-07-21

  DiI (DiIC18(3)) is a robust plasma membrane orange fluorescent probe designed for high-contrast membrane labeling in live or fixed cells. It is particularly suited for applications like neuronal tracing, cell migration assays, and membrane-specific analyses where organic solvent protocols are feasible. DiI is not recommended for water-based staining or exclusive organelle labeling.

455 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page